CLINICAL_TRIALS
trial_result
· 2021-07-28
Clinical Trial Update: Tolerance Following Peanut Oral Immunotherapy [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating tolerance after peanut oral immunotherapy completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-28